{"id":3141,"date":"2025-12-18T15:59:41","date_gmt":"2025-12-18T15:59:41","guid":{"rendered":"https:\/\/www.cansativa.de\/?p=3141"},"modified":"2025-12-16T16:00:29","modified_gmt":"2025-12-16T16:00:29","slug":"the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation","status":"publish","type":"post","link":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/","title":{"rendered":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”3″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”6″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ uncode_shortcode_id=”166943″][vc_column width=”2\/3″][vc_column_text uncode_shortcode_id=”208527″]Adult-Use Cannabis: Decriminalization\u00a0With\u00a0Measurable Effects<\/span><\/b>\u00a0<\/span><\/p>\n

With the Cannabis Act entering into force in April 2024, cannabis consumption in Germany was comprehensively re-regulated for the first time.\u00a0A central\u00a0objective\u00a0of the reform was to decriminalize consumption while steering it responsibly from a public health perspective. One year later, the first interim report by the\u00a0<\/span>ECOCAN<\/span><\/a>\u00a0evaluation group appointed by the federal government delivered important\u00a0initial\u00a0findings in the autumn.<\/span>\u00a0<\/span><\/p>\n

No increase in cannabis use among children and adolescents could be\u00a0identified. Other\u00a0frequently\u00a0voiced concerns \u2014 such as an escalation of public consumption or significant\u00a0additional\u00a0burdens on municipalities \u2014 are likewise not supported by the available data. The evaluation therefore substantiates key assumptions of the reform and, for the first time, provides a robust empirical basis for further political debate.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Limited Access Pathways and the Absence of Model Projects<\/span><\/b>\u00a0<\/span><\/p>\n

At the same time, the\u00a0<\/span>evaluation report<\/span><\/a>\u00a0makes clear that practical implementation in the adult-use sector has fallen short of expectations. Legal access pathways\u00a0remain\u00a0severely limited. Cannabis cultivation associations are struggling with complex approval procedures in many regions, and the number of licensed clubs\u00a0remains\u00a0well below\u00a0initial\u00a0projections.<\/span>\u00a0<\/span><\/p>\n

In addition,\u00a0not a single one\u00a0of the planned\u00a0<\/span>research projects<\/span><\/a>\u00a0has been approved, despite\u00a0numerous\u00a0applications having been\u00a0submitted. As a result, precisely those controlled structures are missing that could both improve access and generate\u00a0additional\u00a0data for evidence-based regulatory development \u2014 in stark contrast to countries such as Switzerland, where comparable projects have been running successfully for around a year.<\/span>\u00a0<\/span><\/p>\n

The consequence: the legal adult-use market is currently able to meet existing demand only to\u00a0a very limited\u00a0extent.<\/span><\/b>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Medical Cannabis: Relief, Normalization, and New Momentum<\/span><\/b>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

The new legislation also marked a major shift in the medical cannabis sector. By removing medical cannabis from the scope of narcotics law, a long-standing reform step was completed, lowering access barriers and normalizing care. For patients and physicians alike, this has meant greater room for\u00a0maneuver, reduced stigmatization, and stronger integration into standard medical care.<\/span>\u00a0<\/span><\/p>\n

At the same time, the system remained in a phase of adjustment throughout\u00a0this\u00a0past\u00a0year.\u00a0Reimbursement\u00a0risks and uncertainties in prescribing practices \u2014 particularly for statutory health insurance patients \u2014 persist. Nevertheless, it is unmistakable that medical cannabis has increasingly evolved from a niche product into a relevant segment of healthcare provision.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Market Growth, Telemedicine, and Regulatory Re-Intervention<\/span><\/b>\u00a0<\/span><\/p>\n

This growth is reflected in sharply rising import volumes as well as in the rapid emergence of\u00a0numerous\u00a0telemedicine-based care models. Digital platforms have, for many patients, enabled low-threshold access to medical prescriptions for the first time, while an increasing number of mail-order pharmacies now deliver medications directly to patients\u2019 homes.<\/span>\u00a0<\/span><\/p>\n

The new federal government has responded to these developments by presenting a draft bill to\u00a0<\/span>amend the Medical Cannabis Act (MedCanG)<\/span><\/a>\u00a0in the summer of 2025. With its proposed ban on telemedicine and mail-order dispensing, the reform focuses less on the structural development of medical care and more on restricting and controlling access pathways. As a result, the medical cannabis sector is once again becoming the subject of law-and-order policy debates \u2014 despite its primary anchoring within the healthcare system.<\/span>\u00a0<\/span><\/p>\n

(As of today, 18 December, 9:55 p.m., the\u00a0<\/span><\/i>draft bill<\/span><\/i><\/a>\u00a0is on the agenda of the German Bundestag. Those interested can follow the debate\u00a0<\/span><\/i>live<\/span><\/i><\/a>.)<\/span><\/i>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

A System Put to the Test in Practice<\/span><\/b>\u00a0<\/span><\/p>\n

The developments illustrate how closely market dynamics, care provision, and political steering are intertwined \u2014 and how quickly imbalances can\u00a0emerge\u00a0when individual components function only partially.<\/span>\u00a0<\/span><\/p>\n

The coming year will therefore be decisive in determining whether policymakers succeed in establishing a regulatory framework that does justice to the differing realities involved: a growing market, a heterogeneous patient population \u2014 both within statutory health insurance and among self-pay patients \u2014 pharmacies as central care providers, and prescribing physicians who continue to operate between a duty of care and legal uncertainty.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

As the year\u00a0comes to a close, we wish you peaceful holidays with your families and time to recover from the political and professional demands of everyday life. Health\u00a0remains\u00a0\u2014 regardless of regulatory debates \u2014 the most important asset.<\/span><\/i><\/b>\u00a0<\/span><\/p>\n

We thank all readers of the Cannabis Briefing who have\u00a0accompanied\u00a0us throughout the year. It has been a pleasure to walk this path together and to continuously contextualize developments in the cannabis sector. We wish you a successful start to the new year and look forward to continued exchange.<\/span><\/i><\/b>\u00a0<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=”150887″]Anything else?<\/strong><\/p>\n

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to\u00a0briefing@www.cansativa.de<\/a>. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!<\/p>\n

We wish you a good read!<\/p>\n

Best wishes from both of us,<\/span>[\/vc_column_text][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”742″ media_width_use_pixel=”yes” uncode_shortcode_id=”192986″ media_width_pixel=”100″][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”933932″ subheading=”Founder & Managing Director Cansativa”]Jakob Sons[\/vc_custom_heading][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image media=”741″ media_width_use_pixel=”yes” uncode_shortcode_id=”178400″ media_width_pixel=”100″][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”607403″ subheading=”Founder & Managing Director Cansativa”]Benedikt Sons[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=”100″ gutter_size=”3″ back_color=”color-xsdn” overlay_alpha=”50″ radius=”std” shadow=”std” shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ sticky=”yes” width=”1\/3″ uncode_shortcode_id=”109911″ back_color_type=”uncode-palette”][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”744″ media_width_percent=”100″ uncode_shortcode_id=”159176″][\/vc_column_inner][vc_column_inner column_width_percent=”100″ position_vertical=”middle” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″ uncode_shortcode_id=”680020″][vc_single_image media=”742″ media_width_use_pixel=”yes” uncode_shortcode_id=”192986″ media_width_pixel=”100″][\/vc_column_inner][\/vc_row_inner][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”850716″ subheading=”Founder & Managing Director Cansativa”]Jakob Sons[\/vc_custom_heading][vc_separator sep_color=”,Default”][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”743″ media_width_percent=”100″ uncode_shortcode_id=”886589″][\/vc_column_inner][vc_column_inner column_width_percent=”100″ position_vertical=”middle” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″ uncode_shortcode_id=”680020″][vc_single_image media=”741″ media_width_use_pixel=”yes” uncode_shortcode_id=”178400″ media_width_pixel=”100″][\/vc_column_inner][\/vc_row_inner][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”132885″ subheading=”Founder & Managing Director Cansativa”]Benedikt Sons[\/vc_custom_heading][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

As the year draws to a close, it is worth taking a look back at the developments that shaped cannabis policy in Germany in 2025. The new Cannabis Act marked its first anniversary, the new federal government initiated evaluations in some areas while moving toward re-regulation in others. Across 22 editions of the Cannabis Briefing, we have followed, contextualized, and discussed these developments. To conclude the year, we revisit the key trajectories that defined cannabis policy in 2025. <\/p>\n","protected":false},"author":5,"featured_media":1736,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[352],"tags":[],"class_list":["post-3141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-briefing-en"],"yoast_head":"\nThe Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group<\/title>\n<meta name=\"description\" content=\"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group\" \/>\n<meta property=\"og:description\" content=\"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/\" \/>\n<meta property=\"og:site_name\" content=\"Cansativa Group\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-18T15:59:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cansativa Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cansativa Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/\"},\"author\":{\"name\":\"Cansativa Admin\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\"},\"headline\":\"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation\",\"datePublished\":\"2025-12-18T15:59:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/\"},\"wordCount\":1174,\"image\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"articleSection\":[\"Briefing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/\",\"name\":\"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"datePublished\":\"2025-12-18T15:59:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\"},\"description\":\"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"contentUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/12\\\/18\\\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#website\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/\",\"name\":\"Cansativa Group\",\"description\":\"We enable Cannabis\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cansativa.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\",\"name\":\"Cansativa Admin\",\"sameAs\":[\"https:\\\/\\\/www.cansativa.de\"],\"url\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/author\\\/alexander-kiefercansativa-de\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group","description":"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/","og_locale":"en_US","og_type":"article","og_title":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group","og_description":"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.","og_url":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/","og_site_name":"Cansativa Group","article_published_time":"2025-12-18T15:59:41+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","type":"image\/png"}],"author":"Cansativa Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Cansativa Admin","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#article","isPartOf":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/"},"author":{"name":"Cansativa Admin","@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca"},"headline":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation","datePublished":"2025-12-18T15:59:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/"},"wordCount":1174,"image":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","articleSection":["Briefing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/","url":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/","name":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation - Cansativa Group","isPartOf":{"@id":"https:\/\/www.cansativa.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#primaryimage"},"image":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","datePublished":"2025-12-18T15:59:41+00:00","author":{"@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca"},"description":"Year in review in the Cansativa Cannabis Briefing: cannabis policy in 2025, ECOCAN evaluation, medical and adult-use cannabis at a glance.","breadcrumb":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#primaryimage","url":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","contentUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.cansativa.de\/en\/2025\/12\/18\/the-year-2025-cannabis-policy-between-decriminalization-and-re-regulation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.cansativa.de\/en\/"},{"@type":"ListItem","position":2,"name":"The Year 2025 \u2013 Cannabis Policy Between Decriminalization and Re-Regulation"}]},{"@type":"WebSite","@id":"https:\/\/www.cansativa.de\/#website","url":"https:\/\/www.cansativa.de\/","name":"Cansativa Group","description":"We enable Cannabis","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cansativa.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca","name":"Cansativa Admin","sameAs":["https:\/\/www.cansativa.de"],"url":"https:\/\/www.cansativa.de\/en\/author\/alexander-kiefercansativa-de\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/3141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/comments?post=3141"}],"version-history":[{"count":1,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/3141\/revisions"}],"predecessor-version":[{"id":3143,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/3141\/revisions\/3143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/media\/1736"}],"wp:attachment":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/media?parent=3141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/categories?post=3141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/tags?post=3141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}